Table 3 Linear regression analysis of baseline selenoprotein P concentrations with clinical parameters at baseline.

From: Serum selenoprotein P, but not selenium, predicts future hyperglycemia in a general Japanese population

Parameters at baseline

SELENOP concentration at baseline (n = 76)

Selenium concentration at baseline (n = 44)

p value

r

p value

r

Age

0.028*

0.252

0.001**

0.501

Body weight

0.177

−0.157

0.217

−0.190

BMI (kg/m2)

0.721

−0.042

0.225

0.187

Waist Circumference (cm)

0.844

−0.023

0.029*

0.329

Fasting plasma glucose (mg/dl)

0.092

0.194

0.102

0.250

Plasma glucose 30 min (mg/dl)

0.036*

0.241

0.716

0.056

Plasma glucose 60 min (mg/dl)

0.004**

0.326

0.373

0.138

Plasma glucose 120 min (mg/dl)

0.797

0.030

0.866

−0.026

Fasting IRI (µU/ml)

0.498

−0.079

0.694

0.061

IRI 30 min (µU/ml)

0.261

−0.130

0.046*

−0.302

IRI 60 min (µU/ml)

0.107

0.187

0.932

−0.013

IRI 120 min (µU/ml)

0.874

−0.018

0.216

−0.190

HbA1c (%)

0.331

0.113

0.571

0.088

HOMA-IR

0.723

−0.041

0.501

0.104

Insulinogenic index

0.010*

−0.293

0.070

−0.276

AST (IU/L)

0.737

−0.039

0.021

−0.347

ALT (IU/L)

0.472

−0.084

0.089

−0.259

Triglyceride (mg/dl)

0.970

0.004

0.426

−0.123

  1. *p < 0.05, **p < 0.01.
  2. BMI, body mass index; IRI, immunoreactive insulin; HbA1c, glycosylated hemoglobin; HOMA-IR, homeostasis model assessment of insulin resistance; AST, aspartate aminotransferase; ALT, alanine aminotransferease; SELENOP, selenoprotein P.